■我们见证了人工智能(AI)技术的巨大进步。乳房手术,普外科的亚专科,尤其受益于AI技术。这篇综述旨在评估人工智能是如何融入乳腺手术实践的,评估其在改善手术结果和操作效率方面的有效性,并确定未来研究和应用的潜在领域。
■两位作者独立对PubMed进行了全面搜索,谷歌学者,EMBASE,和CochraneCENTRAL数据库从1950年1月1日至2023年9月4日,使用与AI相关的关键字与乳腺手术或癌症。搜索的重点是英文出版物,通过仔细筛选标题来确定相关性,摘要,和全文,然后是对这些文章中的参考文献的额外审查。该综述涵盖了一系列研究,说明了AI在乳腺手术中的应用,包括病变诊断到术后随访。专门关注乳房重建的出版物被排除在外。
■AI模型有术前,术中,以及术后在乳腺外科领域的应用。利用乳房成像扫描和患者数据,AI模型已被设计用于预测患乳腺癌的风险,并确定是否需要进行乳腺癌手术。此外,使用乳腺成像扫描和组织病理学切片,模型用于检测,分类,分段,分级,对乳腺肿瘤进行分期.术前应用包括患者教育和预期美学结果的显示。还设计了模型来为精确的肿瘤切除和边缘状态评估提供术中辅助。同样,AI用于预测术后并发症,生存,和癌症复发。
■需要额外的研究才能将AI模型从实验阶段转移到医疗保健中的实际实施。随着AI的快速发展,进一步的应用,预计在未来几年,包括直接执行乳房手术。乳房外科医生应该更新人工智能在乳房手术中的应用进展,为患者提供最好的护理。
UNASSIGNED: We have witnessed tremendous advances in artificial intelligence (AI) technologies. Breast surgery, a subspecialty of general surgery, has notably benefited from AI technologies. This
review aims to evaluate how AI has been integrated into breast surgery practices, to assess its effectiveness in improving surgical outcomes and operational efficiency, and to identify potential areas for future research and application.
UNASSIGNED: Two authors independently conducted a comprehensive search of PubMed, Google Scholar, EMBASE, and Cochrane CENTRAL databases from January 1, 1950, to September 4, 2023, employing keywords pertinent to AI in conjunction with breast surgery or cancer. The search focused on English language publications, where relevance was determined through meticulous screening of titles, abstracts, and full-texts, followed by an additional
review of references within these articles. The
review covered a range of studies illustrating the applications of AI in breast surgery encompassing lesion diagnosis to postoperative follow-up. Publications focusing specifically on breast reconstruction were excluded.
UNASSIGNED: AI models have preoperative, intraoperative, and postoperative applications in the field of breast surgery. Using breast imaging scans and patient data, AI models have been designed to predict the risk of breast cancer and determine the need for breast cancer surgery. In addition, using breast imaging scans and histopathological slides, models were used for detecting, classifying, segmenting, grading, and staging breast tumors. Preoperative applications included patient education and the display of expected aesthetic outcomes. Models were also designed to provide intraoperative assistance for precise tumor resection and margin status assessment. As well, AI was used to predict postoperative complications, survival, and cancer recurrence.
UNASSIGNED: Extra research is required to move AI models from the experimental stage to actual implementation in healthcare. With the rapid evolution of AI, further applications are expected in the coming years including direct performance of breast surgery. Breast surgeons should be updated with the advances in AI applications in breast surgery to provide the best care for their patients.